Publications Database

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)

Faretra G. , Dooher L. , Dowling J. (1970)

Comparison of haloperidol and fluphenazine in disturbed children.

American Journal of Psychiatry

126(11), pp. 1670-1673.

Read Abstract (New Window)

Gencer O. et al. (2008)

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder : An open label maintenance study.

European Child and Adolescent Psychiatry

17(4), pp. 217-225

Read Abstract (New Window)

Ghaziuddin M. , Tsai L. Y. , Ghaziuddin N. (1991)

Brief report: haloperidol treatment of trichotillomania in a boy with autism and mental retardation.

Journal of Autism and Developmental Disorders

21(3), pp. 365-371

Read Abstract (New Window)

Hamrin V. et al. (2008)

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Minerva Pediatrics

60(1), pp. 87-101

Read Abstract (New Window)

Hoshino Y. et al. (1979)

Effects of small doses of haloperidol on autistic children.

Fukushima Journal of Medical Science

26(1), pp. 43-54

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Miral S. et al. (2008)

Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial.

European Child and Adolescent Psychiatry

17(1), pp. 1-8.

Read Abstract (New Window)

Ornitz E. M. (1985)

Should autistic children be treated with haloperidol?

American Journal of Psychiatry

142(7), pp. 883-884

Perry R. et al. (1989)

Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration.

Journal of the American Academy of Child and Adolescent Psychiatry

28 pp. 87-92

Read Abstract (New Window)

American Society of Health-System Pharmacists (2008)

Haloperidol.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. et al. (2008)

Antipsychotics in the treatment of autism.

Journal of Clinical Investigation

118(1), pp. 6-14

Read Abstract (New Window) Read Full (New Window)

Sanchez L. e. et al. (1995)

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Psychopharmacology Bulletin

31(2), pp. 371-378.

Read Abstract (New Window)

Serrano. A. (1981)

Haloperidol: its use in children.

Journal of Clinical Psychiatry

42(4), pp. 154-156

Read Abstract (New Window)

Silva R. R. et al. (1993)

Haloperidol withdrawal and weight changes in autistic children.

Psychopharmacology Bulletin

29(2), pp. 287-291

Read Abstract (New Window)

Tyrer P. et al. (2008)

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.

Lancet

371(9606), pp. 57-63.

Read Abstract (New Window)